James Luterman ’90, a Bucknell University alumnus, was recently appointed senior vice president, research & development at OvaScience, a global fertility company that focuses on discovery, development and commercialization of new treatment options.
Luterman has been at OvaScience since 2014 and also previously held positions at Shire Human Genetic Therapies and Biogen and Decision Resources Group. He has a bachelor’s degree in biology and psychology from Bucknell, as well as a doctorate in behavioral and neural sciences from Rutgers University.